2007
DOI: 10.1016/j.aquaculture.2007.04.066
|View full text |Cite
|
Sign up to set email alerts
|

An oral nervous necrosis virus vaccine that induces protective immunity in larvae of grouper (Epinephelus coioides)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
43
0
12

Year Published

2011
2011
2019
2019

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 79 publications
(60 citation statements)
references
References 27 publications
1
43
0
12
Order By: Relevance
“…Oral vaccination can be standardized to prevent disease occurring at the early larval stage. For example, Artemia-encapsulated recombinant Escherichia coli expressing the NNV capsid protein gene delivered through oral route showed a certain degree of protection after challenge with NNV (relative percentage survival up to 69.5 %) [73]. The protection efficacy can be improved by manipulating the expression in the host.…”
Section: Disease Control Strategiesmentioning
confidence: 99%
“…Oral vaccination can be standardized to prevent disease occurring at the early larval stage. For example, Artemia-encapsulated recombinant Escherichia coli expressing the NNV capsid protein gene delivered through oral route showed a certain degree of protection after challenge with NNV (relative percentage survival up to 69.5 %) [73]. The protection efficacy can be improved by manipulating the expression in the host.…”
Section: Disease Control Strategiesmentioning
confidence: 99%
“…Pathogen invasion results in terrible losses or complete annihilation of stock while rearing fish, especially at the larval stages [3]. Immunoprophylactic methods such as vaccination or immunostimulation are useful against disease outbreaks [4,5]. These methods have been widely used to prevent and control disease transmission in the poultry industry as a form of biosecurity, and are now being applied to aquaculture [6].…”
Section: Introductionmentioning
confidence: 98%
“…Numerous vaccines have been developed with an aim to control NNV: formalin-inactivated virus (Kai and Chi, 2008;Pakingking et al, 2009;Yamashita et al, 2005), binary ethylenimine (BEI)-inactivated virus (Barnes et al, 2005;Kai and Chi, 2008), recombinant protein (Barnes et al, 2005;Husgard et al, 2001;Lin et al, 2007;Sommerset et al, 2005;Tanaka et al, 2001;Vimal et al, 2014a) and DNA based vaccines (Sommerset et al, 2005;Vimal et al, 2014b). The protective immunity conferred by a given vaccine is most commonly evaluated in trials by the analysis of the relative percent survival (RPS) of vaccinated and nonvaccinated fish.…”
Section: Introductionmentioning
confidence: 99%